57,000 units of the epilepsy and migraine relief drug Topamax are being recalled after an “uncharacteristic odor” was found to be emanating from some of the product.
Two lots of Topamax are affected by the recall, involving bottles that contain 60 pills. The latest recall due to a product’s smell is the same issue that sparked recalls in October 2010, July 2010, January 2010 and December 2009– a chemical used to treat wood pallets on which product is stored.
WebMD spoke to a McNeil rep, and the following Topamax lots and varieties are affected:
The company says in a statement that the two lots involved in the recall were shipped between Oct. 19, 2010, and Dec. 28, 2010, and distributed in the U.S. and Puerto Rico. The recall includes Topamax with NDC code 50458-641-65 and lot numbers OKG110 with an expiration date of 06-2012 and OLG222 with an expiration date of 09-2012.
As the issue has been ongoing, Johnson & Johnson had this to say about eliminating it:
It says it is investigating what has happened to cause the consumer complaints and is trying to understand how the chemical is “impacting our supply chains and what we can do to further mitigate this exposure.”
A small number of those exposed have reported temporary and minor gastrointestinal symptoms.